v3.26.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Revenue:        
Total revenue $ 3,604,000 $ 6,392,000 $ 11,538,000 $ 16,630,000
Costs and expenses:        
Cost of revenue 4,850,000 6,068,000 14,902,000 16,753,000
Selling, general and administrative (including stock-based compensation) 2,926,000 3,558,000 10,082,000 10,261,000
Total costs and expenses 7,776,000 9,626,000 24,984,000 27,014,000
Operating loss (4,172,000) (3,234,000) (13,446,000) (10,384,000)
Other income (expense):        
Interest income 5,000 2,000 8,000 17,000
Interest income on note receivable, related party 5,000 7,000 17,000 25,000
Dividend income 4,000 16,000 4,000
Other income (expense) 1,000 (13,000) 10,000
Interest expense (113,000) (38,000) (241,000) (194,000)
Foreign Currency Translation Adjustment (9,000) (1,000) 12,000 (1,000)
Gain on extinguishment of debt 595,000 595,000
Loss on equity method investment (491,000) 2,000 (869,000) (4,000)
(Loss) gain on investments (229,000) 477,000 (1,760,000) 1,105,000
Impairment of intangible assets (600,000)
Loss on sale of assets (35,000) (43,000) (35,000) (727,000)
Loss from operations before income taxes (5,038,000) (2,229,000) (16,311,000) (10,154,000)
Income tax benefit 67,000
Net loss (5,038,000) (2,229,000) (16,311,000) (10,087,000)
Loss from operations attributed to noncontrolling interest 392,000 (70,000) 1,265,000 903,000
Net loss attributable to DSS common stockholders $ (4,646,000) $ (2,299,000) $ (15,046,000) $ (9,184,000)
Loss per common share attributable to common stockholders - operations        
Basic $ (0.46) $ (0.25) $ (1.52) $ (1.03)
Diluted $ (0.46) $ (0.25) $ (1.52) $ (1.03)
Shares used in computing loss per common share:        
Basic 10,042,518 9,092,518 9,913,031 8,957,482
Diluted 10,042,518 9,092,518 9,913,031 8,957,482
Printed Products [Member]        
Revenue:        
Total revenue $ 3,371,000 $ 4,994,000 $ 10,778,000 $ 13,249,000
Rental [Member]        
Revenue:        
Total revenue 162,000 718,000 554,000 2,147,000
Commercial Lending [Member]        
Revenue:        
Total revenue 6,000 7,000 17,000 36,000
Commission [Member]        
Revenue:        
Total revenue 45,000 662,000 160,000 1,166,000
Biotechnology [Member]        
Revenue:        
Total revenue $ 20,000 $ 11,000 $ 29,000 $ 32,000